Cargando…

Retraction Note: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis

Detalles Bibliográficos
Autores principales:	Hu, Jialiang, Wang, Wenjing, Liu, Chen, Li, Mengwei, Nice, Edouard, Xu, Hanmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Retraction Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025398/ https://www.ncbi.nlm.nih.gov/pubmed/32066476 http://dx.doi.org/10.1186/s13046-020-1538-8

Ejemplares similares

Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis
por: Hu, Jialiang, et al.
Publicado: (2019)

From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib
por: Abdel-Aziz, Amal Kamal, et al.
Publicado: (2017)

Biphasic Effect of Pirfenidone on Angiogenesis
por: Gan, Donghao, et al.
Publicado: (2022)

Integrins as attractive targets for cancer therapeutics
por: Li, Meng, et al.
Publicado: (2021)

The Protective Effect of a Long-Acting and Multi-Target HM-3-Fc Fusion Protein in Rheumatoid Arthritis
por: Huang, Ruijing, et al.
Publicado: (2018)

Combined administration of PTX and S-HM-3 in TPGS/Solutol micelle system for oncotarget therapy
por: Li, Weiguang, et al.
Publicado: (2019)

Corrigendum: From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib
por: Abdel-Aziz, Amal Kamal, et al.
Publicado: (2018)

Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas
por: Li, Mengwei, et al.
Publicado: (2020)

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis
por: Hao, Jingchao, et al.
Publicado: (2017)

Shedding New Light on The Role of ανβ3 and α5β1 Integrins in Rheumatoid Arthritis
por: Morshed, Arwa, et al.
Publicado: (2019)

Efficacy of a Selective Binder of α(V)β(3) Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models
por: Sartori, Andrea, et al.
Publicado: (2019)

HM71224, a selective Bruton’s tyrosine kinase inhibitor, attenuates the development of murine lupus
por: Kim, Yu-Yon, et al.
Publicado: (2017)

Compartmentalization of integrin α6β4 signaling in lipid rafts
por: Gagnoux-Palacios, Laurent, et al.
Publicado: (2003)

Membrane lipid rafts are required for AMPA receptor tyrosine phosphorylation
por: Hayashi, Takashi
Publicado: (2022)

Sunitinib Suppress Neuroblastoma Growth through Degradation of MYCN and Inhibition of Angiogenesis
por: Calero, Raul, et al.
Publicado: (2014)

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab
por: Walraven, Maudy, et al.
Publicado: (2018)

The role of integrins in inflammation and angiogenesis
por: Mezu-Ndubuisi, Olachi J., et al.
Publicado: (2020)

H.M. the Emperor of Ethiopia
por: CERN PhotoLab
Publicado: (1967)

ST-HM: not only cranes
por: Bertone, C
Publicado: (2002)

ST-HM equipment consolidation
por: Rühl, I, et al.
Publicado: (2003)

Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib
por: Gotink, Kristy J., et al.
Publicado: (2015)

Effects of integrin-mediated cell adhesion on plasma membrane lipid raft components and signaling
por: Norambuena, Andrés, et al.
Publicado: (2011)

Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis
por: Jiang, Huijiao, et al.
Publicado: (2023)

Formulation and optimisation of raft-forming chewable tablets containing H(2) antagonist
por: Prajapati, Shailesh T, et al.
Publicado: (2012)

Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to Bone
por: Moritz, Milene N.O., et al.
Publicado: (2021)

Integrin signaling is critical for pathological angiogenesis
por: Mahabeleshwar, Ganapati H., et al.
Publicado: (2006)

Novel roles for integrins in tumour angiogenesis
por: Germain, M, et al.
Publicado: (2006)

Rafts to the front; rafts to the rear
por: Wells, William A.
Publicado: (2001)

Effective Antiviral Activity of the Tyrosine Kinase Inhibitor Sunitinib Malate against Zika Virus
por: Lin, Chen-Sheng, et al.
Publicado: (2021)

The case history of 'Sir H.M.'.
por: Longfield-Jones, G M
Publicado: (1988)

H.M. King George at Lincoln
Publicado: (1918)

H.M. Queen Alexandra's Letter
por: Alexandra,
Publicado: (1918)

Adenylate Cyclase Toxin Promotes Internalisation of Integrins and Raft Components and Decreases Macrophage Adhesion Capacity
por: Martín, César, et al.
Publicado: (2011)

Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts
por: Palacios-Moreno, Juan, et al.
Publicado: (2015)

QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis
por: Zhao, Tangliang, et al.
Publicado: (2021)

Inhibition of angiogenesis and tumor progression of MK-0429, an integrin αvβ(3) antagonist, on oral squamous cell carcinoma
por: Nakagawa, Takayuki, et al.
Publicado: (2022)

Theory of mechanochemical patterning in biphasic biological tissues
por: Recho, Pierre, et al.
Publicado: (2019)

Hm-MyD88 and Hm-SARM: Two key regulators of the neuroimmune system and neural repair in the medicinal leech
por: Rodet, F., et al.
Publicado: (2015)

The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical Study
por: Bernard, Valérie, et al.
Publicado: (2016)

Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib
por: Huang, Qiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6skqu22rsiu03gmj2ur394gp62